MUC5B and idiopathic pulmonary fibrosis: Given that the MUC5B promoter variant is the dominant risk factor for developing IPF, our findings suggest that enhanced expression of MUC5B in nonfibrotic unaffected lungs may induce early changes that predispose the lung to fibrosis by establishing a vulnerable bronchoalveolar epithelium.